The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $70.07

Today's change+0.18 +0.26%
Updated May 6 4:02 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $70.07

Today's change+0.18 +0.26%
Updated May 6 4:02 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc crosses above 125-day moving average

Quest Diagnostics Inc closed up Wednesday by (U.S.)$0.18 or 0.26% to (U.S.)$70.07 and crossing above its 125-day moving average. Shares have lost 3.02% over the last five days, but have gained 4.49% over the last year to date. This security has outperformed the S&P 500 by 14.72% during the last year.

Key company metrics

  • Open(U.S.) $70.04
  • Previous close(U.S.) $69.89
  • High(U.S.) $70.41
  • Low(U.S.) $69.47
  • Bid / Ask-- / --
  • YTD % change+4.49%
  • Volume1,593,979
  • Average volume (10-day)1,509,454
  • Average volume (1-month)1,535,509
  • Average volume (3-month)1,545,189
  • 52-week range(U.S.) $55.08 to (U.S.) $78.33
  • Beta0.61
  • Trailing P/E20.06×
  • P/E 1 year forward14.64×
  • Forward PEG1.77×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.17%
  • Trailing EPS(U.S.) $3.49
Updated May 6 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.25%

Based on its net profit margin of 7.25%, Quest Diagnostics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.99%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue1,8397,4351,9041,902
Total other revenue--------
Total revenue1,8397,4351,9041,902
Gross profit6962,819733732
Total cost of revenue1,1434,6161,1711,170
Total operating expense1,6116,4521,6481,640
Selling / general / administrative4081,705437434
Research & development--------
Depreciation / amortization21942425
Interest expense (income), net operating--------
Unusual expense (income)31441610
Other operating expenses, total8-701
Operating income228983256262
Interest income (expense), net non-operating---167-42-42
Gain (loss) on sale of assets--------
Other--------
Income before tax112849221229
Income after tax70587139142
Income tax, total422628287
Net income61556129133
Total adjustments to net income---2-10
Net income before extra. items61551129133
Minority interest-9-36-10-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items61549128133
Inc. avail. to common incl. extra. items61554128133
Diluted net income61554128133
Dilution adjustment--------
Diluted weighted average shares146145145145
Diluted EPS excluding extraordinary itemsvalue per share0.423.790.880.92
Dividends per sharevalue per share0.331.290.330.33
Diluted normalized EPSvalue per share0.554.000.950.96